Pulse Biosciences (NASDAQ:PLSE) Upgraded at StockNews.com

StockNews.com upgraded shares of Pulse Biosciences (NASDAQ:PLSE) to a sell rating in a research note issued to investors on Wednesday morning.

Pulse Biosciences Price Performance

PLSE opened at $21.40 on Wednesday. The company has a 50-day moving average of $17.31 and a 200-day moving average of $15.77. Pulse Biosciences has a 1-year low of $6.59 and a 1-year high of $22.69.

Pulse Biosciences (NASDAQ:PLSE) last issued its earnings results on Wednesday, October 30th. The company reported ($0.21) EPS for the quarter. During the same period in the prior year, the business posted ($0.19) earnings per share.

Hedge Funds Weigh In On Pulse Biosciences

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its stake in Pulse Biosciences by 28.8% during the 1st quarter. Vanguard Group Inc. now owns 847,212 shares of the company’s stock valued at $7,379,000 after acquiring an additional 189,227 shares in the last quarter. Creative Planning lifted its holdings in Pulse Biosciences by 113.9% in the third quarter. Creative Planning now owns 21,910 shares of the company’s stock worth $384,000 after purchasing an additional 11,667 shares during the period. Cetera Advisors LLC acquired a new stake in Pulse Biosciences in the first quarter worth about $109,000. Price T Rowe Associates Inc. MD acquired a new position in Pulse Biosciences during the 1st quarter valued at about $88,000. Finally, Quest Partners LLC acquired a new position in Pulse Biosciences during the 2nd quarter valued at about $91,000. 76.95% of the stock is owned by institutional investors.

Pulse Biosciences Company Profile

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.